ID: ALA20089

Max Phase: Preclinical

Molecular Formula: C23H31N3NaO5P

Molecular Weight: 461.50

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC(C)CC(NC(Cc1ccccc1)NP(=O)([O-])CNC(=O)Cc1ccccc1)C(=O)O.[Na+]

Standard InChI:  InChI=1S/C23H32N3O5P.Na/c1-17(2)13-20(23(28)29)25-21(14-18-9-5-3-6-10-18)26-32(30,31)16-24-22(27)15-19-11-7-4-8-12-19;/h3-12,17,20-21,25H,13-16H2,1-2H3,(H,24,27)(H,28,29)(H2,26,30,31);/q;+1/p-1

Standard InChI Key:  QUNIYLQGZLXIBE-UHFFFAOYSA-M

Associated Targets(Human)

Angiotensin-converting enzyme 1423 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Neprilysin 537 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Angiotensin-converting enzyme-related carboxypeptidase 13 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 461.50Molecular Weight (Monoisotopic): 461.2080AlogP: 2.74#Rotatable Bonds: 13
Polar Surface Area: 127.76Molecular Species: ZWITTERIONHBA: 4HBD: 5
#RO5 Violations: 0HBA (Lipinski): 8HBD (Lipinski): 5#RO5 Violations (Lipinski): 0
CX Acidic pKa: 1.83CX Basic pKa: 9.52CX LogP: 0.68CX LogD: -2.13
Aromatic Rings: 2Heavy Atoms: 32QED Weighted: 0.23Np Likeness Score: -0.07

References

1. Elliott RL, Marks N, Berg MJ, Portoghese PS..  (1985)  Synthesis and biological evaluation of phosphonamidate peptide inhibitors of enkephalinase and angiotensin-converting enzyme.,  28  (9): [PMID:2993614] [10.1021/jm00147a015]

Source